Ruoyong Yang

1.5k total citations
33 papers, 1.1k citations indexed

About

Ruoyong Yang is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Ruoyong Yang has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 9 papers in Physiology and 8 papers in Pharmacology. Recurrent topics in Ruoyong Yang's work include Schizophrenia research and treatment (8 papers), Pain Mechanisms and Treatments (7 papers) and Bipolar Disorder and Treatment (7 papers). Ruoyong Yang is often cited by papers focused on Schizophrenia research and treatment (8 papers), Pain Mechanisms and Treatments (7 papers) and Bipolar Disorder and Treatment (7 papers). Ruoyong Yang collaborates with scholars based in United States, France and United Kingdom. Ruoyong Yang's co-authors include James O. Berger, Jean Endicott, Jonathan Sporn, John Nee, Antony Loebel, Bruce Parsons, Luis Sanin, Joseph M. Scavone, Lloyd Knapp and Stephen A. Murray and has published in prestigious journals such as Neurology, Journal of the American Academy of Child & Adolescent Psychiatry and Neuropsychopharmacology.

In The Last Decade

Ruoyong Yang

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruoyong Yang United States	18	341	232	226	181	154	33	1.1k
Laura Ación United States	23	480 1.4×	175 0.8×	250 1.1×	72 0.4×	159 1.0×	53	2.3k
Alok Krishen United States	21	459 1.3×	846 3.6×	140 0.6×	167 0.9×	421 2.7×	32	2.0k
Rainer Schaub Germany	18	301 0.9×	90 0.4×	170 0.8×	88 0.5×	59 0.4×	31	1.1k
Gerald Novak United States	29	1.5k 4.3×	428 1.8×	98 0.4×	60 0.3×	97 0.6×	83	2.8k
Haochang Shou United States	29	380 1.1×	303 1.3×	92 0.4×	63 0.3×	62 0.4×	84	2.3k
Frank Miller United States	21	298 0.9×	80 0.3×	66 0.3×	372 2.1×	92 0.6×	113	1.6k
Ed Whalen United States	18	649 1.9×	958 4.1×	78 0.3×	40 0.2×	697 4.5×	59	2.0k
John W. Goethe United States	24	533 1.6×	130 0.6×	452 2.0×	19 0.1×	221 1.4×	75	1.6k
Gregory G. Enas United States	13	164 0.5×	61 0.3×	62 0.3×	201 1.1×	193 1.3×	25	1.6k
Brice Ozenne Denmark	22	125 0.4×	72 0.3×	1.0k 4.5×	148 0.8×	202 1.3×	105	2.5k

Countries citing papers authored by Ruoyong Yang

Since Specialization

Citations

This map shows the geographic impact of Ruoyong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruoyong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruoyong Yang more than expected).

Fields of papers citing papers by Ruoyong Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruoyong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruoyong Yang. The network helps show where Ruoyong Yang may publish in the future.

Co-authorship network of co-authors of Ruoyong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruoyong Yang. A scholar is included among the top collaborators of Ruoyong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruoyong Yang. Ruoyong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schnitzer, Thomas J., Philip G. Conaghan, Francis Bérenbaum, et al.. (2024). Effect size varies based on calculation method and may affect interpretation of treatment effect: an illustration using randomised clinical trials in osteoarthritis. Advances in Rheumatology. 64(1). 31–31. 1 indexed citations

Abraham, Lucy, Robert H. Dworkin, Dennis C. Turk, et al.. (2023). Examining the Relationships Among Treatment, Pain, and Physical Function in Patients With Osteoarthritis. Clinical Journal of Pain. 39(4). 159–165. 1 indexed citations

Mease, Philip J., Louis Kuritzky, Wendy L. Wright, et al.. (2022). Efficacy and safety of tanezumab, NSAIDs, and placebo in patients with moderate to severe hip or knee osteoarthritis and a history of depression, anxiety, or insomnia: post-hoc analysis of phase 3 trials. Current Medical Research and Opinion. 38(11). 1909–1922. 6 indexed citations

Markman, John D., Thomas J. Schnitzer, Serge Perrot, et al.. (2022). Clinical Meaningfulness of Response to Tanezumab in Patients with Chronic Low Back Pain: Analysis From a 56-Week, Randomized, Placebo- and Tramadol-Controlled, Phase 3 Trial. Pain and Therapy. 11(4). 1267–1285. 4 indexed citations

Schnitzer, Thomas J., Francis Bérenbaum, Philip G. Conaghan, et al.. (2021). Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis. Rheumatology and Therapy. 8(4). 1759–1774. 3 indexed citations

Raskin, Philip, Cynthia Huffman, Lorraine Yurkewicz, et al.. (2015). Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy Using an NSAID for Other Pain Conditions. Clinical Journal of Pain. 32(3). 203–210. 20 indexed citations

Chelly, Jacques E., David R. Lionberger, Joseph Gimbel, et al.. (2014). Pregabalin for the treatment of postoperative pain: results from three controlled trials using different surgical models. Journal of Pain Research. 8. 9–9. 41 indexed citations

Sjölund, Karl‐Fredrik, Ruoyong Yang, Kyung-Hee Lee, & Malca Resnick. (2013). Randomized Study of Pregabalin in Patients with Cancer-Induced Bone Pain. Pain and Therapy. 2(1). 37–48. 18 indexed citations

Lombardo, Ilise, Gary Sachs, Sheela Kolluri, C.M.E. Kremer, & Ruoyong Yang. (2012). Two 6-Week, Randomized, Double-Blind, Placebo-Controlled Studies of Ziprasidone in Outpatients With Bipolar I Depression. Journal of Clinical Psychopharmacology. 32(4). 470–478. 48 indexed citations

10.

Robb, Adelaide S., Jeanette E. Cueva, Jonathan Sporn, Ruoyong Yang, & Douglas Vanderburg. (2010). Sertraline Treatment of Children and Adolescents With Posttraumatic Stress Disorder: A Double-Blind, Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 20(6). 463–471. 61 indexed citations

11.

Yang, Xiao‐Jun, et al.. (2009). PROBLEMS OF LOCAL FRACTIONAL DEFINITE INTEGRAL OF THE ONEVARIABLE NONDIFFERENTIABLE FUNCTION. World Sci-tech R & D. 31(6). 722–724. 13 indexed citations

12.

Citrome, Leslie, Ruoyong Yang, Paul Glue, & Onur N. Karayal. (2009). Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: A post-hoc analysis of 4 fixed-dose randomized clinical trials. Schizophrenia Research. 111(1-3). 39–45. 15 indexed citations

13.

Weiden, Peter J., John W. Newcomer, Antony Loebel, Ruoyong Yang, & Harold E. Lebovitz. (2007). Long-Term Changes in Weight and Plasma Lipids during Maintenance Treatment with Ziprasidone. Neuropsychopharmacology. 33(5). 985–994. 62 indexed citations

14.

Zimbroff, Dan, Lewis Warrington, Antony Loebel, Ruoyong Yang, & Cynthia Siu. (2007). Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study. International Clinical Psychopharmacology. 22(6). 363–370. 40 indexed citations

15.

Rynn, Moira A., Karen Dineen Wagner, Craig L. Donnelly, et al.. (2006). Long-Term Sertraline Treatment of Children and Adolescents with Major Depressive Disorder. Journal of Child and Adolescent Psychopharmacology. 16(1-2). 103–116. 18 indexed citations

16.

Loebel, Antony, et al.. (2006). Change in Framingham Risk Score in Patients With Schizophrenia. The Primary Care Companion For CNS Disorders. 8(6). 329–33. 6 indexed citations

17.

Olié, Jean‐Pierre, Edoardo Spina, Stephen A. Murray, & Ruoyong Yang. (2006). Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study. International Clinical Psychopharmacology. 21(3). 143–151. 52 indexed citations

18.

Endicott, Jean, et al.. (2006). Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q): Reliability and Validity. Journal of the American Academy of Child & Adolescent Psychiatry. 45(4). 401–407. 109 indexed citations

19.

Donnelly, Craig L., Karen Dineen Wagner, Moira A. Rynn, et al.. (2006). Sertraline in Children and Adolescents With Major Depressive Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 45(10). 1162–1170. 17 indexed citations

20.

Connor, Kathryn M., Jonathan Davidson, Henry Chung, Ruoyong Yang, & Cathryn M. Clary. (2005). Multidimensional effects of sertraline in social anxiety disorder. Depression and Anxiety. 23(1). 6–10. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact